跳至主要内容
临床试验/CTRI/2024/04/065939
CTRI/2024/04/065939尚未招募3 期

EFFICACY OF BACOPA MONNEIRI IN ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SCHOOL & COLLEGE GOING AGE GROUP : RANDOMISED CONTROLLED TRIAL USING SNAP-IV SCORE

Dr Saroj Ranjit Sawant1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年4月27日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Swanson Nolan And Pelham Rating Scale

研究概览

简要总结

Efficacy of Bacopa Monneiri in ADHD in school going & college going age group  will be studied by Randomized controlled clinical trial using outcome assessment SNAP IV score. The sample size whole study will be 100 cases,

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
6.00 Year(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • •Children & young persons of a mixed variety of Attention Deficit Hyperactivity Disorder as per DSM 5 Criteria Children & young persons of WITH ENLISH Literate Parents.

排除标准

  • •Children with any chronic physical or neurological disorder History of drug abuse History of seizure History of Tic disorder History of Tourette syndrome Severely ill in need of hospitalization and patients who are on anti ADHD or psychoactive medications in the previous 2wks.

结局指标

主要结局

Swanson Nolan And Pelham Rating Scale

时间窗: PRESTUDY MIDSTUDY POSTSTUDY

SNAP IV 26 items

时间窗: PRESTUDY MIDSTUDY POSTSTUDY

次要结局

未报告次要终点

研究者

发起方
Dr Saroj Ranjit Sawant
申办方类型
Other [Scholar self]
责任方
Principal Investigator
主要研究者

Dr Saroj Ranjit Sawant

Maharashtra University of Health Sciences Nashik

研究点 (1)

Loading locations...

相似试验